| Saudi Arabia has been asserting itself on the world stage of late. But in Riyadh, officials are scrambling to stem rising unemployment, which may shrink support for Crown Prince Mohammed bin Salman as he tries to wean the kingdom off of its reliance on oil. —David E. Rovella Here are today's top stories When it comes to oil, America has become too big to ignore. China quietly illustrated this by removing U.S. crude from its list of targeted goods in the ongoing global trade war. U.S. Vice President Mike Pence announced that President Donald Trump will ask Congress for $8 billion over five years to establish the U.S. Space Force as a sixth branch of the military. Tesla shares fell back to earth as questions multiplied over Elon Musk's tweet earlier this week about taking the electric carmaker private. The ruble dropped after the U.S. announced new sanctions over Russia's alleged use of a chemical weapon in an attempt to kill a former spy in the U.K. Moscow threatened retaliation. Times are tough at Deutsche Bank. Cost-cutting has forced investment bankers to endure traveling in coach class on trains and forgoing daily fruit bowls. Hockey night in Seattle may be in trouble thanks to Trump's trade war. The cost of rebuilding the KeyArena, which will host an expansion National Hockey League team, is climbing. What's Luke Kawa thinking about? The Bloomberg markets reporter says the trade war is having little effect on U.S. risk assets, but China's tech heavyweights can't get off the mat. What you'll need to know tomorrow Welcome to lifestyles of the rich and shameless in Singapore. Rockets fired by Palestinians drew air strikes from Israel. Sanctions are pushing Iran's economy into crisis mode. "The Dude" bets $100 million on Turkish stocks while everyone else seeks safety. The Kansas Republican primary got even closer after a mistake was discovered. New York Governor Andrew Cuomo took a chunk out of Trump over a capital gains tax cut. Rents are falling in Brooklyn's once-hip Williamsburg as a subway shutdown looms. Sponsored by Purdue Pharma We make prescription opioids. And we want to limit their use.
For over 25 years, we’ve developed opioid medications for patients with chronic pain, and we are acutely aware of the public health risks they can create. As such, we believe the country needs a new approach to prescribing opioids. What you'll want to read tonight Despite a love of red meat, more Americans are turning to plant-based imitators, which have a mixed record of tasting anything like flesh. Now there's a burger made out of the same components that go into real beef, but it's cultured in the lab. Can you get past the ick factor? Like Bloomberg's Evening Briefing? Subscribe to Bloomberg All Access and get much, much more. You'll receive our unmatched global news coverage and two in-depth daily newsletters, The Bloomberg Open and The Bloomberg Close. Never miss an update: Introducing @tictoc, the first and only global news network built for Twitter. You’ll find 24/7 coverage by 2,700 Bloomberg journalists and analysts, reporting from 120 countries. Download the Bloomberg app: It's available for iOS and Android. | 